Hong Kong Drug Regulators To Step Up Inspections To Improve Drug Safety
This article was originally published in PharmAsia News
HONG KONG - Hong Kong regulators may step up inspections of drug manufacturing facilities outside the former British enclave following a series of recommendations in December to improve drug safety
You may also be interested in...
Major changes are afoot in Hong Kong’s drug approval and regulatory process with safety a prime focus following a series of reforms implemented last year in response to six deaths from spurious generic drugs in 2009.
SHANGHAI - The Association of Southeast Asian Nations is slated to implement common technical documents starting this year as part of "harmonized" pharmaceutical regulations in the region, which could benefit consumers by 2010
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).